💸
💰 Goldman Stacks 💰
June 18, 2026 · posted by Cam
Trading Post Roundup · June 15–16, 2026

Burry backed up the truck

Cam · June 18, 2026

Burry dropped two Trading Posts back-to-back last week on Cassandra Unchained and added to five full positions across two days. Instead of making the crew read two walls of text, here's the cheat sheet — every buy, every fill, the reasons that matter. Gang's got you.

The 5 Buys

FISVFiserv · payments infra
Fill~$48–49
Full Position 5–7% 10-yr Low Castle Tier
  1. 1License to print money. Core bank processing = 99% retention, brutal switching costs, reaches 95% of US households. Runs fine regardless of who's CEO.
  2. 2Record EPS, dog of a stock. $226 → sub-$48 in a bull market, yet 2026 EPS affirmed at all-time-high ~$8+. Trades 1.4× his $35 fair value — edge of the fat-pitch zone.
  3. 3Stablecoin + agentic optionality. FIUSD "flip the switch" once Genius Act rules land July 2026. Owns merchant rails AND deposit accounts.
BABAAlibaba ADS · China tech
Fill~$109.50
Full Position P/S Collapsed
  1. 1Revenue up-and-to-the-right while the stock fell 70–80%. Gross margin at or near ATH the whole time.
  2. 2Keeps investing and taking share while smaller Chinese names stall out.
  3. 3HK free-fall is flows, not fundamentals. US/Korea/Japan rotation + headline fear = mispricing.
ZTSZoetis · animal health
Fill~$78.70
Full Position Forever Hold?
  1. 1One-of-one. Only pure-play global animal-health name with stellar, steady ROI. Nothing else like it.
  2. 2Volume swell = closing in on the low. The tape is talking.
  3. 3Recent troubles far overstated for a name Burry is considering a potential forever hold.
VEEVVeeva · life-sci SaaS
Fill~$160.60
Becoming Full AI-Resistant
  1. 1Significant moat. Entrenched system-of-record for pharma and life sciences — nobody rips this out.
  2. 2Not at real risk from "AI." The fear hammering other SaaS names simply doesn't apply here.
  3. 3"A solid fat pitch" on his All Map. Volume swell hinting at a bottom.
JDJD.com ADS · China retail
Fill~$28.30
Very Full P/S Collapsed
  1. 1Same setup as BABA. Revenue climbing while stock crashed 70–80%. P/S collapsed to nothing.
  2. 2Gross margin elevated through the entire drawdown. Business didn't break — narrative did.
  3. 3Burry calls it "very full" — one of his biggest adds across both Trading Posts.

Watch · Trim · Pass

BYD
Watch

Closing in on his buy zone in the mid-$70s as HK sells off. Not bought yet — but on the radar.

BRKRP
Trim

Sold part of the Bruker preferred in the low $420s after a 50% run. Still likes it, just sized down.

SPCX
Pass

Tempted by puts, said "no thank you." Flags the $2.8T cap on under $20B revenue as absurd — but walked.

Cam's Take

Common thread across all five: cash-printing leaders at decade lows because flows and narrative left, not because the businesses broke. Revenue still rising, margins at or near highs, volume swells hinting at bottoms. It's the "buy the franchise, not the headline" trade. Gang's watching this basket.

📄 Source Posts

Check the distillation against the originals — Burry's two Trading Posts, reprinted for the crew.

15
Jun
Trading Post June 15, 2026
The FISV deep dive — Castle-tier moat, FIUSD, agentic commerce, fat-pitch math.
16
Jun
Trading Post June 16, 2026
The five-pick day — BABA, ZTS, VEEV, JD, FISV, trimmed BRKRP, roasted SpaceX.
Not financial advice. Goldman Stacks is a group chat having fun. Prices are sourced figures, not live quotes. Source posts are reprinted from Burry's paid Cassandra Unchained Substack for the crew's private review. Do your own work and size your own risk.
‹ back to the board